Product Information
COSOPT PF EYE DROPS is a brand product labeled by Thea Pharma Inc., priced at $3.2995 per EA under NDC 82584060430. Its NADAC has been published 172 times since Jun 21, 2023.
FDA first approved this application on Feb 1, 2012. Its Orange Book therapeutic-equivalence code is AT2.
The High Outlier badge above means this manufacturer's average price in the dorzolamide hydrochloride and timolol maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20; 5 mg/mL; mg/mL
Manufacturer
Thea Pharma Inc.NDC
82584060430
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA202667FDA Approved
2/1/2012
TE Code
AT2
On Market Since
12/10/2022
Pharmacological Classes
Price Statistics
The NADAC for COSOPT PF EYE DROPS has been published 172 times since Jun 21, 2023, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2995 per EA |
|---|---|
| All-time high | $3.3072 (Nov 13, 2024) |
| All-time low | $3.0452 (Jun 21, 2023) |
| 52-week high | $3.3031 |
| 52-week low | $3.2995 |
| Median price | $3.3011 |
| Average price | $3.2341 |
| Largest weekly change | +8.0% (May 8, 2024) |
| Weeks tracked | 172 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dorzolamide hydrochloride and timolol maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Thea Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dorzolamide hydrochloride and timolol maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COSOPT PF EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for COSOPT PF EYE DROPS, manufactured by Thea Pharma Inc., is $3.2995 per EA (NDC 82584060430), effective Sep 30, 2026.
How has the price of COSOPT PF EYE DROPS changed over time?
Over the history we have for it, the NADAC for COSOPT PF EYE DROPS has risen 8.4%. It has been tracked across 172 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for COSOPT PF EYE DROPS?
Since Jun 21, 2023, the NADAC for COSOPT PF EYE DROPS has ranged from a low of $3.0452 (Jun 21, 2023) to a high of $3.3072 (Nov 13, 2024), with a median of $3.3011 per EA.
Are there cheaper alternatives to COSOPT PF EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of COSOPT PF EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COSOPT PF EYE DROPS?
COSOPT PF EYE DROPS (NDC 82584060430) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.